These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27199259)

  • 1. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
    Muthuswamy R; Corman JM; Dahl K; Chatta GS; Kalinski P
    Prostate; 2016 Sep; 76(12):1095-105. PubMed ID: 27199259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.
    Muthuswamy R; Wang L; Pitteroff J; Gingrich JR; Kalinski P
    J Immunother Cancer; 2015; 3():6. PubMed ID: 25806105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.
    Muthuswamy R; Berk E; Junecko BF; Zeh HJ; Zureikat AH; Normolle D; Luong TM; Reinhart TA; Bartlett DL; Kalinski P
    Cancer Res; 2012 Aug; 72(15):3735-43. PubMed ID: 22593190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
    Gandhi S; Opyrchal M; Grimm MJ; Slomba RT; Kokolus KM; Witkiewicz A; Attwood K; Groman A; Williams L; Tarquini ML; Wallace PK; Soh KT; Minderman H; Maguire O; O'Connor TL; Early AP; Levine EG; Kalinski P
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37963636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.
    Fujita M; Kohanbash G; Fellows-Mayle W; Hamilton RL; Komohara Y; Decker SA; Ohlfest JR; Okada H
    Cancer Res; 2011 Apr; 71(7):2664-74. PubMed ID: 21324923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors.
    Lin L; Kane N; Kobayashi N; Kono EA; Yamashiro JM; Nickols NG; Reiter RE
    Clin Cancer Res; 2021 Mar; 27(5):1505-1515. PubMed ID: 33219015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
    Wiedemann GM; Röhrle N; Makeschin MC; Fesseler J; Endres S; Mayr D; Anz D
    Pathology; 2019 Oct; 51(6):586-592. PubMed ID: 31445808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
    Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
    Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFκB-Activated COX2/PGE
    Ibrahim OM; Basse PH; Jiang W; Guru K; Chatta G; Kalinski P
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells.
    Padovan E; Spagnoli GC; Ferrantini M; Heberer M
    J Leukoc Biol; 2002 Apr; 71(4):669-76. PubMed ID: 11927654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell mediated induction of allogeneic endothelial cell chemokine expression.
    Kobayashi H; Koga S; Novick AC; Toma H; Fairchild RL
    Transplantation; 2003 Feb; 75(4):529-36. PubMed ID: 12605122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes.
    Yan L; Da Silva DM; Verma B; Gray A; Brand HE; Skeate JG; Porras TB; Kanodia S; Kast WM
    Prostate; 2015 Feb; 75(3):280-91. PubMed ID: 25399517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation.
    Muthuswamy R; Urban J; Lee JJ; Reinhart TA; Bartlett D; Kalinski P
    Cancer Res; 2008 Jul; 68(14):5972-8. PubMed ID: 18632653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.
    Kang S; Xie J; Ma S; Liao W; Zhang J; Luo R
    Immunobiology; 2010; 215(2):153-62. PubMed ID: 19450895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.
    Hossain DM; Pal SK; Moreira D; Duttagupta P; Zhang Q; Won H; Jones J; D'Apuzzo M; Forman S; Kortylewski M
    Clin Cancer Res; 2015 Aug; 21(16):3771-82. PubMed ID: 25967142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
    Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment.
    Theodoraki MN; Yerneni S; Sarkar SN; Orr B; Muthuswamy R; Voyten J; Modugno F; Jiang W; Grimm M; Basse PH; Bartlett DL; Edwards RP; Kalinski P
    Cancer Res; 2018 Aug; 78(15):4292-4302. PubMed ID: 29853604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.